Pattern of Lymphatic Spread of Esophageal Cancer at the Cervicothoracic Junction Based on the Tumor Location

详细信息    查看全文

• 作者：Makoto Yamasaki MD ; Hiroshi Miyata MD ; Yasuhiro Miyazaki MD…
• 刊名：Annals of Surgical Oncology
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：22
• 期：3-supp
• 页码：750-757
• 全文大小：524 KB
• 参考文献：1.Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMed CrossRef
  2.Siewert JR, Stein HJ. Adenocarcinoma of the gastroesophageal junction classification, pathology and extent of resection. Dis Esophagus. 1996;9:173–82.
  3.Siewert JR, Feith M, Wermer M, Stein HJ. Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients. Ann Surg. 2000;232:353–62.CrossRef
  4.Siewert JR, Stein HJ, Feith M. Adenocarcinoma of the esophagogastric junction. Scan J Surg. 2006;95:260–9.
  5.Yabusaki H, Nashimoto A, Matsuki A, Aizawa M. Comparison of the surgical treatment strategies for Siewert type II squamous cell carcinoma in the same area as esophagogastric junction carcinoma: data from a single Japanese high-volume cancer center. Surg Today. 2014;44:1522–8.PubMed PubMedCentral CrossRef
  6.Jang HJ, Lee HS, Kim MS, Lee JM, Zo JI. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma. Ann Thorac Surg. 2011;92:1091–7.PubMed CrossRef
  7.Shimada H, Okazumi S, Shiratori T, Akutsu Y, Matsubara H. Mode of lymphadenectomy and surgical outcome of upper thoracic esophageal squamous cell carcinoma. J Gastrointest Surg. 2009;13:619–25.PubMed CrossRef
  8.Martins AS. Neck and mediastinal node dissection in pharyngolaryngoesophageal tumors. Head Neck. 2001;23:772–9.PubMed CrossRef
  9.Hirano S, Nagahara K, Moritani S, Kitamura M, Takagita S. Upper mediastinal node dissection for hypopharyngeal and cervical esophageal carcinomas. Ann Otol Rhinol Laryngol. 2007;116:290–6.PubMed CrossRef
  10.Fujita H. The history of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery. Surg Today. 2015;45:140–9.PubMed CrossRef
  11.Yanagawa M, Tatsumi M, Miyata H, Morii E, Tomiyama N, Watabe T, Isohashi K, Kato H, Shimosegawa E, Yamasaki M, Mori M, Doki Y, Hatazawa J. Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors. J Nucl Med. 2012;53:872–80.PubMed CrossRef
  12.Zhong X, Yu J, Zhang B, Mu D, Zhang W, Li D, Han A, Song P, Li H, Yang G, Kong FM, Fu Z. Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2009;73:136–41.PubMed CrossRef
  13.Yamasaki M, Miyata H, Fujiwara Y, et al. p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus. Ann Surg Oncol. 2010;17:634–42.PubMed CrossRef
  14.Yamasaki M, Miyata H, Tanaka K, et al. Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus. Oncology. 2011;80:307–13.PubMed CrossRef
  15.Miyata H, Yamasaki M, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. Larynx-preserving limited resection and free jejunal graft for carcinoma of the cervical esophagus. World J Surg. 2013;37:551–7.PubMed CrossRef
  16.Fujita H, Kakegawa T, Yamana H, Sueyoshi S, Hikita S, Mine T, Tanaka Y, Ishikawa H, Shirouzu K, Mori K, Inoue Y, Tanabe HY, Kiyokawa K, Tai Y, Inutsuka H. Total esophagectomy versus proximal esophagectomy for esophageal cancer at the cervicothoracic junction. World J Surg. 1999;23:486–91.PubMed CrossRef
  17.Drudi FM, Trippa F, Cascone F, et al. Esophagogram and CT vs endoscopic and surgical specimens in the diagnosis of esophageal carcinoma. Radiol Med. 2002;103:344–52.PubMed
  18.Leong T, Everitt C, Yuen K, et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol. 2006;78:254–61.PubMed CrossRef
  19.Konski A, Doss M, Milestone B, et al. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:1123–8.PubMed CrossRef
  
• 作者单位：Makoto Yamasaki MD (1)
  Hiroshi Miyata MD (1)
  Yasuhiro Miyazaki MD (1)
  Tsuyoshi Takahashi MD (1)
  Yukinori Kurokawa MD (1)
  Kiyokazu Nakajima MD (1)
  Shuji Takiguchi MD (1)
  Masaki Mori MD (1)
  Yuichiro Doki MD (1)
  
  1. Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
  
• 刊物主题：Surgical Oncology; Oncology; Surgery;
• 出版者：Springer US
• ISSN：1534-4681

文摘

Background There is no consensus about the extent of lymphadenectomy for patients with esophageal squamous cell carcinoma at the cervicothoracic junction (CT-ESCC). The purpose of this study was to examine the pattern of lymph node spread in patients with CT-ESCC and the extent of lymphadenectomy that is necessary.